Use In Specific Populations 8.1 Pregnancy Risk Summary Published studies with use of insulin glargine products during pregnancy have not reported a clear association with insulin glargine products and adverse developmental outcomes (see Data)
Arthur JC, Perez-Chanona E, Mhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C: Intestinal inflammation targets cancer-inducing activity of the microbiota
They help the body make a little more insulin after eating meals to help process glucose and they help people feel full
GLP-1 medications are highly sensitive to heat and freezing, requiring a temperature-controlled environment that balances stability, compliance, and patient care